Is ACKAY Stock Undervalued?
A comprehensive valuation analysis of Arcelik AS ADR (ACKAY) examining current multiples, intrinsic value, and comparing to analyst expectations.
Valuation Verdict
Potentially Undervalued
144403707727.6% upside potential
Based on our analysis, Arcelik AS ADR appears to be potentially undervalued at the current price of $14.36. Our fair value estimate of $20736372444.05 suggests upside potential of approximately 144403707727.6%.
Current Valuation Metrics
Valuation ratios help us understand how the market is pricing ACKAY relative to its fundamentals. Let's examine the key multiples investors are paying today.
Understanding the Metrics
- P/E Ratio: Not currently profitable or data unavailable.
- P/B Ratio: A P/B of 1.04 means investors pay $1.04 for every $1 of book value.
- P/S Ratio: The price-to-sales ratio of 0.18 indicates how much investors value each dollar of revenue.
- EV/EBITDA: This ratio of 14.50 helps compare ACKAY to peers while accounting for debt.
Fair Value Estimate
Using a discounted cash flow (DCF) model, we estimate the intrinsic value of Arcelik AS ADR stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.
Our DCF model suggests ACKAY may be undervalued by approximately 144403707727.6%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.
Investment Conclusion
Bottom Line
Based on our comprehensive valuation analysis, Arcelik AS ADR (ACKAY) appears to be undervalued at $14.36. With a fair value estimate of $20736372444.05, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.
More Analysis for ACKAY
Compare with Peers
See how Arcelik AS ADR stacks up against similar companies
Popular Valuation Analysis
Explore valuation analysis for top stocks
Related: ACKAY Dividend, ACKAY Growth, ACKAY Financial Health
Compare: ACKAY vs AAPL, ACKAY vs MSFT, ACKAY vs GOOGL